Probing the topological tolerance of multimeric protein interactions: Evaluation of an estrogen/synthetic ligand for FK506 binding protein conjugate

Bioconjugate Chemistry

Volumn 21, Issue 10, 2010, Pages 1880-1889

  Moore, Terry W ^a,b   Gunther, Jillian R ^a   Katzenellenbogen, John A ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^b EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIMERS; TOPOLOGY;

COACTIVATORS; ESTROGEN RECEPTOR; FK506-BINDING PROTEINS; INTERACTION EVALUATIONS; MULTIMERIC; OESTROGENS; PROTEIN CONJUGATES; PROTEIN INTERACTION; SMALL MOLECULES; SYNTHETIC LIGANDS;

PROTEINS;

BINDING PROTEIN; DIMER; ESTROGEN; ESTROGEN RECEPTOR ALPHA; LIGAND; TACROLIMUS;

ANIMAL CELL; ARTICLE; ASSAY; BACTERIAL GENE; CONJUGATE; DIMERIZATION; IN VITRO STUDY; MOLECULAR WEIGHT; NONHUMAN; PROTEIN INTERACTION; PROTEIN PROTEIN INTERACTION; RECEPTOR BINDING; REPORTER GENE;

EID: 77958171625     PISSN: 10431802     EISSN: 15204812     Source Type: Journal    
DOI: 10.1021/bc100266v     Document Type: Article

References (41)

1. Tamrazi, A., Carlson, K. E., Daniels, J. R., Hurth, K. M., and Katzenellenbogen, J. A. (2002) Estrogen receptor dimerization: ligand binding regulates dimer affinity and dimer dissociation rate Mol. Endocrinol. 16, 2706-2719
2. Gee, A. C., Carlson, K. E., Martini, P. G., Katzenellenbogen, B. S., and Katzenellenbogen, J. A. (1999) Coactivator peptides have a differential stabilizing effect on the binding of estrogens and antiestrogens with the estrogen receptor Mol. Endocrinol. 13, 1912-23
3. Moore, T. W. and Katzenellenbogen, J. A. (2009) Inhibitors of Nuclear Hormone Receptor/Coactivator Interactions Annu. Rep. Med. Chem. 44, 443-457
4. Vaz, B., Mocklinghoff, S., and Brunsveld, L. (2008) Targeting the nuclear receptor-cofactor interaction, in Nuclear Receptors as Drug Targets (Ottow, F. and Weinmann, H., Eds.) pp 25 - 45, Wiley-VCH, Weinheim, Germany.
5. Yudt, M. R. and Koide, S. (2001) Preventing estrogen receptor action with dimer-interface peptides Steroids 66, 549-58
6. Moore, T. W., Mayne, C. G., and Katzenellenbogen, J. A. (2010) Minireview: not picking pockets: nuclear receptor alternate-site modulators (NRAMs) Mol. Endocrinol. 24, 683-695
7. Shiau, A. K., Barstad, D., Loria, P. M., Cheng, L., Kushner, P. J., Agard, D. A., and Greene, G. L. (1998) The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen Cell 95, 927-37
8. Parent, A. A., Gunther, J. R., and Katzenellenbogen, J. A. (2008) Blocking estrogen signaling after the hormone: pyrimidine-core inhibitors of estrogen receptor-coactivator binding J. Med. Chem. 51, 6512-6530
9. Rodriguez, A. L., Tamrazi, A., Collins, M. L., and Katzenellenbogen, J. A. (2004) Design, synthesis, and in vitro biological evaluation of small molecule inhibitors of estrogen receptor α coactivator binding J. Med. Chem. 47, 600-611
10. Arkin, M. R. and Wells, J. A. (2004) Small-molecule inhibitors of protein-protein interactions: progressing towards the dream Nat. Rev. Drug Discovery 3, 301-17
11. Wells, J. A. and McClendon, C. L. (2007) Reaching for high-hanging fruit in drug discovery at protein-protein interfaces Nature 450, 1001-9
12. Gestwicki, J. E., Crabtree, G. R., and Graef, I. A. (2004) Harnessing chaperones to generate small-molecule inhibitors of amyloid beta aggregation Science 306, 865-869
13. Gestwicki, J. E. and Marinec, P. S. (2007) Chemical control over protein-protein interactions: beyond inhibitors Comb. Chem. High Throughput Screen. 10, 667-75
14. Arpino, G., Wiechmann, L., Osborne, C. K., and Schiff, R. (2008) Crosstalk between the estrogen receptor and the HER tyrosine kinase receptor family: molecular mechanism and clinical implications for endocrine therapy resistance Endocr. Rev. 29, 217-33
15. Anstead, G. M., Carlson, K. E., and Katzenellenbogen, J. A. (1997) The estradiol pharmacophore: Ligand structure-estrogen receptor binding affinity relationships and a model for the receptor binding site Steroids 62, 268-303
16. Gao, H., Katzenellenbogen, J. A., Garg, R., and Hansch, C. (1999) Comparative QSAR analysis of estrogen receptor ligands Chem. Rev. 99, 723-744
17. Pangborn, A. B., Giardello, M. A., Grubbs, R. H., Rosen, R. K., and Timmers, F. J. (1996) Safe and convenient procedure for solvent purification Organometallics 15, 1518-1520
18. Still, W. C., Kahn, M., and Mitra, A. (1978) Rapid chromatographic technique for preparative separations with moderate resolution J. Org. Chem. 43, 2923-25
19. Holt, D. A., Luengo, J. I., Yamashita, D. S., Oh, H. J., Konialian, A. L., Yen, H. K., Rozamus, L. W., Brandt, M., Bossard, M. J., Levy, M. A., Eggleston, D. S., Liang, J., Schultz, L. W., Stout, T. J., and Clardy, J. (1993) Design, synthesis, and kinetic evaluation of high-affinity FKBP Ligands and the X-ray crystal-structures of their complexes with FKBP12 J. Am. Chem. Soc. 115, 9925-9938
20. Keenan, T., Yaeger, D. R., Courage, N. L., Rollins, C. T., Pavone, M. E., Rivera, V. M., Yang, W., Guo, T., Amara, J. F., Clackson, T., Gilman, M., and Holt, D. A. (1998) Synthesis and activity of bivalent FKBP12 ligands for the regulated dimerization of proteins Bioorg. Med. Chem. 6, 1309-35
21. Carlson, K. E., Choi, I., Gee, A., Katzenellenbogen, B. S., and Katzenellenbogen, J. A. (1997) Altered ligand binding properties and enhanced stability of a constitutively active estrogen receptor: Evidence that an open pocket conformation is required for ligand interaction Biochemistry 36, 14897-14905
22. Vilella-Bach, M., Nuzzi, P., Fang, Y. M., and Chen, J. (1999) The FKBP12-rapamycin-binding domain is required for FKBP12-rapamycin-associated protein kinase activity and G(1) progression J. Biol. Chem. 274, 4266-4272
23. Gunther, J. R., Du, Y., Rhoden, E., Lewis, I., Revennaugh, B., Moore, T. W., Kim, S. H., Dingledine, R., Fu, H., and Katzenellenbogen, J. A. (2009) A set of time-resolved fluorescence resonance energy transfer assays for the discovery of inhibitors of estrogen receptor-coactivator binding J. Biomol. Screen. 14, 181-193
24. Sun, J., Meyers, M. J., Fink, B. E., Rajendran, R., Katzenellenbogen, J. A., and Katzenellenbogen, B. S. (1999) Novel ligands that function as selective estrogens or antiestrogens for estrogen receptor-alpha or estrogen receptor-beta Endocrinology 140, 800-804
25. Ward, B. K., Mark, P. J., Ingram, D. M., Minchin, R. F., and Ratajczak, T. (1999) Expression of the estrogen receptor-associated immunophilins, cyclophilin 40 and FKBP52, in breast cancer Breast Cancer Res. Treat. 58, 267-80
26. Clackson, T., Yang, W., Rozamus, L. W., Hatada, M., Amara, J. F., Rollins, C. T., Stevenson, L. F., Magari, S. R., Wood, S. A., Courage, N. L., Lu, X., Cerasoli, F., Jr., Gilman, M., and Holt, D. A. (1998) Redesigning an FKBP-ligand interface to generate chemical dimerizers with novel specificity Proc. Natl. Acad. Sci. U.S.A. 95, 10437-42
27. Katzenellenbogen, J. A., Johnson, H. J., and Carlson, K. E. (1973) Studies on uterine, cytoplasmic estrogen binding protein-thermal-stability and ligand dissociation rate-assay of empty and filled sites by exchange Biochemistry 12, 4092-4099
28. Nettles, K. W., Bruning, J. B., Gil, G., O'Neill, E. E., Nowak, J., Guo, Y., Kim, Y., DeSombre, E. R., Dilis, R., Hanson, R. N., Joachimiak, A., and Greene, G. L. (2007) Structural plasticity in the oestrogen receptor ligand-binding domain EMBO Rep. 8, 563-8
29. LaFrate, A. L., Gunther, J. R., Carlson, K. E., and Katzenellenbogen, J. A. (2008) Synthesis and biological evaluation of guanylhydrazone coactivator binding inhibitors for the estrogen receptor Bioorg. Med. Chem. 16, 10075-10084
30. Shao, D., Berrodin, T. J., Manas, E., Hauze, D., Powers, R., Bapat, A., Gonder, D., Winneker, R. C., and Frail, D. E. (2004) Identification of novel estrogen receptor α antagonists J. Steroid Biochem. Mol. Biol. 88, 351-360
31. Kelley, N. W., Vishal, V., Krafft, G. A., and Pande, V. S. (2008) Simulating oligomerization at experimental concentrations and long timescales: A Markov state model approach J. Chem. Phys. 129, 214707
32. Garzon-Rodriguez, W., Sepulveda-Becerra, M., Milton, S., and Glabe, C. G. (1997) Soluble amyloid Abeta-(1-40) exists as a stable dimer at low concentrations J. Biol. Chem. 272, 21037-44
33. Wu, J. W., Breydo, L., Isas, J. M., Lee, J., Kuznetsov, Y. G., Langen, R., and Glabe, C. Fibrillar oligomers nucleate the oligomerization of monomeric amyloid beta but do not seed fibril formation J. Biol. Chem. 285, 6071-9
34. Singh, P., Hallur, G., Anchoori, R. K., Bakare, O., Kageyama, Y., Khan, S. R., and Isaacs, J. T. (2008) Rational design of novel antiandrogens for neutralizing androgen receptor function in hormone refractory prostate cancer Prostate 68, 1570-81
35. Marinec, P. S., Lancia, J. K., and Gestwicki, J. E. (2008) Bifunctional molecules evade cytochrome P(450) metabolism by forming protective complexes with FK506-binding protein Mol. Biosyst. 4, 571-8
36. Katzenellenbogen, J. A. and Zablocki, J. A. (1987) Cytotoxic Oestrogens and Antioestrogens: Concepts, Progress and Evaluation, in Pharmacology and clinical uses of inhibitors of hormone secretion and action (Furr, B. J. A. and Wakeling, A. E., Eds.) pp 41 - 59, Bailliere Tindall, London.
37. Kim, E., Rye, P. T., Essigmann, J. M., and Croy, R. G. (2009) A bifunctional platinum(II) antitumor agent that forms DNA adducts with affinity for the estrogen receptor J. Inorg. Biochem. 103, 256-261
38. Mitra, K., Marquis, J. C., Hillier, S. M., Rye, P. T., Zayas, B., Lee, A. S., Essigmann, J. M., and Croy, R. G. (2002) A rationally designed genotoxin that selectively destroys estrogen receptor-positive breast cancer cells J. Am. Chem. Soc. 124, 1862-1863
39. Rink, S. M., Yarema, K. J., Solomon, M. S., Paige, L. A., Tadayoni-Rebek, B. M., Essigmann, J. M., and Croy, R. G. (1996) Synthesis and biological activity of DNA damaging agents that form decoy binding sites for the estrogen receptor Proc. Natl. Acad. Sci. U.S.A. 93, 15063-15068
40. Kuduk, S. D., Zheng, F. F., Sepp-Lorenzino, L., Rosen, N., and Danishefsky, S. J. (1999) Synthesis and evaluation of geldanamycin-estradiol hybrids Bioorg. Med. Chem. Lett. 9, 1233-8
41. Hussey, S. L., Muddana, S. S., and Peterson, B. R. (2003) Synthesis of a β-estradiol-biotin chimera that potently heterodimerizes estrogen receptor and streptavidin proteins in a yeast three-hybrid system J. Am. Chem. Soc. 125, 3692-3693